Wójcik J, Bułło B, Jassem J, Rutkowski B
Kliniki Onkologii i Radioterapii AM.
Pol Merkur Lekarski. 1998 Sep;5(27):145-6.
Authors present a case of renal transplant recipient treated with a carboplatin-based chemotherapy for testicular embryonal carcinoma. The patient experienced severe treatment-related toxicity and died due to bone marrow aplasia 3 months after the diagnosis of cancer. The safety of platinum-based chemotherapy in renal transplant recipients is discussed with reference to the literature data.
作者报告了一例肾移植受者,其因睾丸胚胎性癌接受了以卡铂为基础的化疗。该患者经历了严重的治疗相关毒性反应,并在癌症诊断后3个月因骨髓再生障碍而死亡。参考文献数据讨论了铂类化疗在肾移植受者中的安全性。